Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

Cited by (772)

Items 201–300 of 772

1. Clinical relevance of liver histopathology and different histological classifications of NASH in adults
   F. Nascimbeni, S. Ballestri, M. Machado, A. Mantovani, H. Cortez-Pinto, G. Targher, A. Lonardo · 2018 · Expert Review of Gastroenterology & Hepatology
2. Prevalence and outcomes of non‐alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States
   Pegah Golabi, James M. Paik, Jessica Park Hwang, Su Wang, Hannah M. Lee, Zobair M. Younossi · 2018 · Liver International
3. Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review
   Raseen Tariq, Page D. Axley, Ashwani K. Singal · 2019 · Journal of Clinical and Experimental Hepatology
4. Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke
   Seung Up Kim, Dongbeom Song, Ji Hoe Heo, Joonsang Yoo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang Joon Kim, Kwang‐Hyub Han et al. · 2017 · Atherosclerosis
5. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance
   Min‐Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kyum Kim, Yoon Jun Kim, Jung‐Hwan Yoon · 2014 · Liver International
6. Serum alanine aminotransferase predicts the histological course of non‐alcoholic steatohepatitis in J apanese patients
   Yuya Seko, Yoshio Sumida, Saiyu Tanaka, Kojiroh Mori, Hiroyoshi Taketani, Hiroshi Ishiba, Tasuku Hara, Akira Okajima, Kanji Yamaguchi, Michihisa Moriguchi et al. · 2014 · Hepatology Research
7. Association between the platelet/high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: results from NHANES 2017–2020
   Chunfeng Lu, Xiaomin Cang, Wangshu Liu, Lihua Wang, Haiyan Huang, Shengmei Sang, Xueqin Wang, Xing-xing Fang, Feng Xu · 2023 · Lipids in Health and Disease
8. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease
   Jun Luo, Li Xu, Jiang Li, Shui-Ping Zhao · 2015 · European Journal of Gastroenterology & Hepatology
9. Non-invasive score identifies ultrasonography-diagnosed non-alcoholic fatty liver disease and predicts mortality in the USA
   Ching‐Lung Cheung, Karen SL Lam, Ian Chi Kei Wong, Bernard M.Y. Cheung · 2014 · BMC Medicine
10. Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency
    Maria Wakolbinger, Renate Kruschitz, Christian Kienbacher, Stefan Traussnigg, Felix Benedikt Langer, Karin Schindler, Tanja Würger, Friedrich Wrba, Michael A Trauner, Gerhard Prager et al. · 2016 · Obesity Surgery
11. Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey
    Joon Ho Moon, Bo Kyung Koo, Won Kyum Kim · 2021 · Journal of Cachexia Sarcopenia and Muscle
12. Sarcopenia Contributes to the Progression of Nonalcoholic Fatty Liver Disease- Related Fibrosis: A Meta-Analysis
    Xiaoyan Pan, Yijing Han, Tiantian Zou, Guiqi Zhu, Ke Xu, Ji-Na Zheng, Ming‐Hua Zheng, Xingbo Cheng · 2018 · Digestive Diseases
13. Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance
    Justin McNair Canada, Antonio Abbate, Rebecca Collen, Hayley Billingsley, Leo Francis Buckley, Salvatore Carbone, Cory Ross Trankle, Michael O. Idowu, Dinesh Kadariya, Benjamin W. Van Tassell et al. · 2018 · The American Journal of Cardiology
14. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline
    Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo J. E. Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarık Kani, Wafaa Khannoussi, L. Lacaze et al. · 2022 · United European Gastroenterology Journal
15. Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023
    Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George T. Cholankeril, Rohit Seth Loomba, Aijaz Ahmed · 2024 · Clinical and Molecular Hepatology
16. Heat Killed Lactobacillus reuteri GMNL-263 Reduces Fibrosis Effects on the Liver and Heart in High Fat Diet-Hamsters via TGF-β Suppression
    Wei‐Jen Ting, Wei‐Wen Kuo, Dennis Jine‐Yuan Hsieh, Yu‐Lan Yeh, Cecilia Hsuan Day, Ya-Hui Chen, Ray‐Jade Chen, Viswanadha Padma, Yi-Hsing Chen, Chih‐Yang Huang · 2015 · International Journal of Molecular Sciences
17. Association between Noninvasive Fibrosis Markers and Chronic Kidney Disease among Adults with Nonalcoholic Fatty Liver Disease
    G. Sesti, T. Fiorentino, F. Arturi, M. Perticone, A. Sciacqua, F. Perticone · 2014 · PLoS ONE
18. Predictors of nonalcoholic steatohepatitis and significant fibrosis in non‐obese nonalcoholic fatty liver disease
    Donghee Kim, Won Kyum Kim, Sae Kyung Joo, Jung Ho Kim, Stephen A. Harrison, Zobair M. Younossi, Aijaz Ahmed · 2018 · Liver International
19. Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
    Chan‐Hee Jung, Eun‐Jung Rhee, Hyemi Kwon, Yoosoo Chang, Seungho Ryu, Won‐Young Lee · 2020 · Endocrinology and Metabolism
20. Perfluorooctanesulfonic acid (PFOS) administration shifts the hepatic proteome and augments dietary outcomes related to hepatic steatosis in mice
    Emily Marques, Marisa Pfohl, Adam Auclair, Rohitash Jamwal, Benjamin J. Barlock, Ferass M. Sammoura, Michael J. Goedken, Fatemeh Akhlaghi, Angela Lucas Slitt · 2020 · Toxicology and Applied Pharmacology
21. The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
    Marcin Kosmalski, Sylwia Ziółkowska, Piotr Lech Czarny, Janusz Szemraj, Tadeusz Pietras · 2022 · Journal of Clinical Medicine
22. Antifibrotic effect and long‐term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus
    Taeang Arai, Masanori Atsukawa, Akihito Tsubota, Shigeru Mikami, Haruki Uojima, Keiichiro Yoshikata, Hiroki Ono, Tadamichi Kawano, Yuji Yoshida, Tomohide Tanabe et al. · 2022 · Hepatology Communications
23. Journal of Gastroenterology and Hepatology: Issue Information
    S. Mahady, Leon A. Adams · 2018 · Journal of Gastroenterology and Hepatology
24. 21st Century Advances in Multimodality Imaging of Obesity for Care of the Cardiovascular Patient
    Ian J. Neeland, Takeshi Yokoo, Olof Dahlqvist Leinhard, Carl J. Lavie · 2020 · JACC. Cardiovascular imaging
25. A simple clinical model predicts incident hepatic steatosis in a community‐based cohort: The Framingham Heart Study
    Michelle T. Long, Alison Pedley, Joseph M. Massaro, Udo Hoffmann, Jiantao Ma, Rohit Seth Loomba, Raymond T. Chung, Emelia J. Benjamin · 2018 · Liver International
26. Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis
    Suzanne E. Mahady, Petra Macaskill, Jonathan C. Craig, Grace Lai‐Hung Wong, Chiu‐Wing Winnie Chu, Henry Lik‐Yuen Chan, Jacob George, Vincent Wai‐Sun Wong · 2017 · Clinical Gastroenterology and Hepatology
27. Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease
    Saba Sayari, Hassan Neishaboori, Maryam Jameshorani · 2018 · Clinical and Molecular Hepatology
28. Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States
    Donghee Kim, Eric R. Yoo, Andrew A. Li, Christopher T. Fernandes, Sean P. Tighe, George T. Cholankeril, Bilal Hameed, Aijaz Ahmed · 2018 · Clinical Gastroenterology and Hepatology
29. Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?
    Narendra Singh Choudhary, Ajay Kumar. Duseja · 2019 · Journal of Clinical and Experimental Hepatology
30. Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study
    Alina M. Allen, Terry M. Therneau, Kristin C. Mara, Joseph J. Larson, Kymberly D. S. Watt, Sharonne N. Hayes, Patrick S. Kamath · 2019 · The American Journal of Gastroenterology
31. Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease.
    S. Ballestri, A. Mantovani, F. Nascimbeni, S. Lugari, A. Lonardo · 2019 · Future Medicinal Chemistry
32. Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population
    Young‐Gyun Seo, Stergios A. Pοlyzos, Kyung‐Hee Park, Christos Socrates Mantzoros · 2023 · Clinical Gastroenterology and Hepatology
33. Astaxanthin prevents and reverses the activation of mouse primary hepatic stellate cells
    Yue Jin Yang, Minkyung Bae, Bohkyung Kim, Young‐Ki Park, Sung I. Koo, Ji‐Young Lee · 2015 · The Journal of Nutritional Biochemistry
34. Progression of liver fibrosis is associated with non‐liver‐related mortality in patients with nonalcoholic fatty liver disease
    Toshifumi Tada, Takashi Kumada, Hidenori Toyoda, Kazuyuki Mizuno, Yasuhiro Sone, Tomoyuki Akita, Junko Tanaka · 2017 · Hepatology Communications
35. The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank
    Theresa Hydes, Oliver John Kennedy, Ryan Malcolm Buchanan, Daniel James Cuthbertson, Julie Parkes, Simon DS Fraser, Paul J. Roderick · 2023 · BMC Medicine
36. Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease
    Vikas K Gupta · 2015 · World Journal of Gastroenterology
37. Nonalcoholic fatty liver disease and measures of early brain health in middle‐aged adults: The CARDIA study
    Lisa B. VanWagner, James Greg Terry, Lisa Senye Chow, Amy C. Alman, Hakmook Kang, Katherine Heimburger Ingram, Christina M. Shay, Cora Elizabeth Lewis, Robert Nick Bryan, Lenore J. Launer et al. · 2017 · Obesity
38. Review of galectin-3 inhibitors in the treatment of nonalcoholic steatohepatitis
    Al Attar, Atef, Antaramian, Ani, Noureddin, Mazen · 2021 · Expert Review of Clinical Pharmacology
39. The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failure
    Tetsuya Takahashi, Tetsu Watanabe, Tetsuro Shishido, Ken Watanabe, Takayuki Sugai, Taku Toshima, Daisuke Kinoshita, Miyuki Yokoyama, Harutoshi Tamura, Satoshi Nishiyama et al. · 2017 · Heart and Vessels
40. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD)
    Michael Patrick Johnston, Janisha A. Patel, Christopher D. Byrne · 2020 · Current Pharmaceutical Design
41. Inhibition of Diacylglycerol Acyltransferase 2 Versus Diacylglycerol Acyltransferase 1: Potential Therapeutic Implications of Pharmacology
    Amin, Neeta B., Saxena, Aditi R., Somayaji, Veena, Dullea, Robert · 2023 · Clinical Therapeutics
42. Non-alcoholic fatty liver disease - the heart of the matter
    Haneen Azzam · 2015 · World Journal of Hepatology
43. Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease
    Noam Peleg, Orly Sneh Arbib, Assaf Issachar, Michal Cohen‐Naftaly, Marius Braun, Amir Shlomai · 2018 · PLoS ONE
44. Steatotic liver disease‐associated all‐cause/cause‐specific mortality in the United States
    Donghee Kim, Karn Wijarnpreecha, George T. Cholankeril, Aijaz Ahmed · 2024 · Alimentary Pharmacology & Therapeutics
45. The ABCC6 Transporter: A New Player in Biomineralization
    Guillaume Favrè, Audrey Laurain, Tamás Arányi, Flóra Szeri, Krisztina Fülöp, Olivier Le Saux, Christophe Duranton, Gilles Kauffenstein, Ludovic Martin, Georges Lefthériotis · 2017 · International Journal of Molecular Sciences
46. Vegetarian diet, food substitution, and nonalcoholic fatty liver
    Chin‐Lon Lin, Tina H. T. Chiu, Ming‐Nan Lin, Wen-Harn Pan, Yen‐Ching Chen · 2018 · Tzu Chi Medical Journal
47. Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease
    Do Seon Song, U I. Chang, Sung Goo Kang, Sang-Wook Song, Jin Mo Yang · 2019 · Gut and Liver
48. Diet quality and its association with nonalcoholic fatty liver disease and all‐cause and cause‐specific mortality
    Eric R. Yoo, Donghee Kim, Luis Miguel Vazquez‐Montesino, Jessica A. Escober, Andrew A. Li, Sean P. Tighe, Christopher T. Fernandes, George T. Cholankeril, Aijaz Ahmed · 2020 · Liver International
49. Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality
    Peter Konyn, Omar S. Alshuwaykh, Brittany Burns Dennis, George T. Cholankeril, Aijaz Ahmed, Donghee Kim · 2022 · Clinical Gastroenterology and Hepatology
50. Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysis
    Yahao Wang, Yue Zhou, Zhihong Wang, Yunzhi Ni, Gérald J. Prud’homme, QINGHUA WANG · 2025 · The Journal of Clinical Endocrinology & Metabolism
51. Trends in hospitalizations for chronic liver disease‐related liver failure in the United States, 2005‐2014
    Donghee Kim, George T. Cholankeril, Andrew A. Li, Won Kyum Kim, Sean P. Tighe, Bilal Hameed, Paul Yien Kwo, Stephen A. Harrison, Zobair M. Younossi, Aijaz Ahmed · 2019 · Liver International
52. Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non‐alcoholic fatty liver disease
    Yejin Kim, Yoosoo Chang, Yong Kyun Cho, Jiin Ahn, Ho Cheol Shin, Seungho Ryu · 2019 · Liver International
53. Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection
    Amine Benmassaoud, Peter Ghali, Joseph Cox, Philip Y.N. Wong, Jason Szabo, Marc Deschênes, Maria Osikowicz, Bertrand Lebouché, Marina B. Klein, Giada Sebastiani · 2018 · PLoS ONE
54. Relationship between non-alcoholic fatty liver disease and coronary heart disease
    Uğur Arslan, Mustafa Yenerçağ · 2020 · World Journal of Clinical Cases
55. Are the different MAFLD subtypes based on the inclusion criteria correlated with all-cause mortality?
    Xu Chen, Shen Chen, Juan Pang, Yi Tang, Wenhua Ling · 2021 · Journal of Hepatology
56. Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
    Lorenz M.W. Holzner, Andrew J. Murray · 2021 · Frontiers in Medicine
57. Correlation between hs-CRP-triglyceride glucose index and NAFLD and liver fibrosis
    Yuhui Zhou, Hao Lin, Xiaochun Weng, Huifang Dai, Jing Xu · 2025 · BMC Gastroenterology
58. Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States
    Seung Joo Kang, Hwa Jung Kim, Donghee Kim, Aijaz Ahmed · 2018 · PLoS ONE
59. Liver fat scores predict liver disease mortality in the United States population
    Aynur Ünalp–Arida, Constance E. Ruhl · 2018 · Alimentary Pharmacology & Therapeutics
60. Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Farah Ahsan, Federico Oliveri, Harshit K Goud, Zainab Mehkari, Lubna Mohammed, Moiz Javed, Aldanah Althwanay, Ian Hunter Rutkofsky · 2020 · Cureus
61. Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma
    Yu‐Han Huang, Chi Chan, Hye Won Lee, Claire Huang, Yen‐Ju Chen, Po-Chun Liu, Sheng‐Nan Lu, Wan‐Long Chuang, Jee‐Fu Huang, Ming‐Lung Yu et al. · 2022 · Clinical Gastroenterology and Hepatology
62. Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
    Rita Basu, Mazen Noureddin, Jeanne M. Clark · 2022 · Mayo Clinic Proceedings
63. Moderate Treadmill Exercise Alleviates NAFLD by Regulating the Biogenesis and Autophagy of Lipid Droplet
    Yangjun Yang, Xi Li, Zonghan Liu, Xinyu Ruan, Huihui Helen Wang, Qiang Zhang, Lu Cao, Luchen Song, Yinghong Chen, Yi Sun · 2022 · Nutrients
64. CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population
    Eduardo Vilar Gómez, Raj Vuppalanchi, Samer Gawrieh, Niharika R. Samala, Naga Chalasani · 2023 · Hepatology
65. Practical guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline
    Stephan C. Bischoff, Johann Ockenga, Ahad Eshraghian, Rocco Barazzoni, Luca Busetto, Marjo J. E. Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Haluk Tarık Kani, Wafaa Khannoussi et al. · 2023 · Clinical Nutrition
66. Current status of fibrosis markers
    Keyur Patel, Nicholas Adam Shackel · 2014 · Current Opinion in Gastroenterology
67. Histone deacetylase 9 plays a role in the antifibrogenic effect of astaxanthin in hepatic stellate cells
    Yue Jin Yang, Minkyung Bae, Young‐Ki Park, Yoojin Lee, Tho Xuan Pham, Swetha Rudraiah, José Enrique Manautou, Sung I. Koo, Ji‐Young Lee · 2016 · The Journal of Nutritional Biochemistry
68. Simple Scores of Fibrosis and Mortality in Patients with NAFLD: A Systematic Review with Meta-Analysis
    Federico Salomone, Agnieszka Micek, Justyna Godos · 2018 · Journal of Clinical Medicine
69. Consenso mexicano de la enfermedad por hígado graso no alcohólico
    Raúl Bernal-Reyes, Graciela Castro‐Narro, René Malé-Velázquez, Ramón Carmona-Sánchez, M.S. González-Huezo, Ignacio García-Juárez, Norberto Carlos Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia et al. · 2019 · Revista de Gastroenterología de México
70. FIB‐4 stage of liver fibrosis predicts incident heart failure among HIV‐infected and uninfected patients
    Kaku So‐Armah, Joseph K. Lim, Vincent Lo Re, Janet P. Tate, Chung‐Chou H. Chang, Adeel Ajwad Butt, Cynthia L. Gibert, David Rimland, Vincent C. Marconi, Matthew Bidwell Goetz et al. · 2017 · Hepatology
71. Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort
    Stergios A. Pοlyzos, Aristidis Slavakis, Georgios Koumerkeridis, Panagiotis Katsinelos, Jannis Kountouras · 2018 · Hormone and Metabolic Research
72. An association of large-fibre peripheral nerve dysfunction with non-invasive measures of liver fibrosis secondary to non-alcoholic fatty liver disease in diabetes
    Kathryn Williams, Kharis A. Burns, Maria Constantino, Nicholas Adam Shackel, Emilia Prakoso, Jencia Wong, Ted Wu, Jacob George, Geoffrey William McCaughan, Stephen Morris Twigg · 2015 · Journal of Diabetes and its Complications
73. Plasminogen activator inhibitor‐1 is independently associated with non‐alcoholic fatty liver disease whereas leptin and adiponectin vary between genders
    Ming‐Ling Chang, Chen‐Ming Hsu, Jeng‐Hwei Tseng, Yung‐Kuan Tsou, Shuchun Chen, Shuen‐Shian Shiau, Chau‐Ting Yeh, Cheng‐Tang Chiu · 2014 · Journal of Gastroenterology and Hepatology
74. Epidemiology of Nonalcoholic Fatty Liver Disease
    Goh Eun Chung, Donghee Kim · 2014 · Korean Journal of Medicine
75. Noninvasive Methods, including Transient Elastography, for the Detection of Liver Disease in Adults with Cystic Fibrosis
    Matthew D Sadler, Pam Crotty, Linda Fatovich, Stephanie R. Wilson, Harvey R Rabin, Robert P. Myers · 2015 · Canadian Journal of Gastroenterology and Hepatology
76. Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification
    Seng Chan You, Kwang Joon Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han · 2015 · Journal of Gastroenterology and Hepatology
77. Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy‐proven Japanese non‐alcoholic fatty liver disease patients
    Takanori Ito, Masatoshi Ishigami, Yoji Ishizu, Teiji Kuzuya, Takashi Honda, Kazuhiko Hayashi, Daisaku Nishimura, Hidenori Toyoda, Takashi Kumada, Hidemi Goto et al. · 2018 · Journal of Gastroenterology and Hepatology
78. Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter
    Stefan Andrei Chiriac, C Stanciu, Irina Gîrleanu, Camelia Cojocariu, Catalin Victor Sfarti, Ana-Maria Sîngeap, Tudor Cuciureanu, Laura Huiban, Cristina Maria Muzica, Sebastian Zenovia et al. · 2021 · Canadian Journal of Gastroenterology and Hepatology
79. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives
    Daniel Clayton‐Chubb, William W. Kemp, Ammar Majeed, John Samuel Lubel, Alex Hodge, Stuart Keith Roberts · 2023 · Nutrients
80. Association between Noninvasive Fibrosis Markers and Cardio-Vascular Organ Damage among Adults with Hepatic Steatosis
    Giorgio Sesti, Angela Sciacqua, Teresa Vanessa Fiorentino, Maria Perticone, Elena Succurro, Francesco Perticone · 2014 · PLoS ONE
81. The Association between Non-Invasive Hepatic Fibrosis Markers and Cardiometabolic Risk Factors in the Framingham Heart Study
    Michelle T. Long, Alison Pedley, Joseph M. Massaro, Udo Hoffmann, Caroline S. Fox · 2016 · PLoS ONE
82. Leucocyte telomere shortening is associated with nonalcoholic fatty liver disease‐related advanced fibrosis
    Donghee Kim, Andrew A. Li, Aijaz Ahmed · 2018 · Liver International
83. Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke
    Neal S. Parikh, Lisa B. VanWagner, Mitchell S.V. Elkind, José Gutierrez · 2019 · Journal of the Neurological Sciences
84. Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary Intervention
    Hui‐Hui Liu, Ye‐Xuan Cao, Jing‐Lu Jin, Qi Hua, Yanfang Li, Yuan‐Lin Guo, Cheng‐Gang Zhu, Na‐Qiong Wu, Runlin Gao, Jian‐Jun Li · 2021 · Journal of the American Heart Association
85. Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity
    Kathryn Williams, A.J. Viera de Ribeiro, Emilia Prakoso, Anne-Sophie Veillard, Nicholas Adam Shackel, Yangmin Bu, Belinda A. Brooks, Erika Cavanagh, J. Raleigh, Susan V. McLennan et al. · 2015 · Diabetes Research and Clinical Practice
86. Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score–matched cohort study
    Namki Hong, Han Gyul Yoon, Da Hea Seo, Seho Park, Seung Il Kim, Joohyuk Sohn, Yumie Rhee · 2017 · European Journal of Cancer
87. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large‐scale multicenter retrospective study
    Hideki Fujii, Yuichiro Suzuki, Koji Sawada, Miwa Tatsuta, Tatsuji Maeshiro, Hiroshi Tobita, Tsubasa Tsutsumi, Takemi Akahane, Chitomi Hasebe, Miwa Kawanaka et al. · 2023 · Hepatology Research
88. Sugar-Sweetened Beverages and Artificially Sweetened Beverages Consumption and the Risk of Nonalcoholic Fatty Liver (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
    Tung‐Sung Tseng, Wei‐Ting Lin, Peng–Sheng Ting, Chiung‐Kuei Huang, Po‐Hung Chen, Gabrielle V. Gonzalez, Hui‐Yi Lin · 2023 · Nutrients
89. Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications
    Luca Miele, Giovanni Targher · 2015 · Expert Review of Gastroenterology & Hepatology
90. Enhanced Liver Fibrosis Test as a Reliable Tool for Assessing Fibrosis in Nonalcoholic Fatty Liver Disease in a Clinical Setting
    L. Miele, Teresa De Michele, G. Marrone, M. Isgrò, U. Basile, C. Cefalo, M. Biolato, F. Vecchio, G. Rapaccini, A. Gasbarrini et al. · 2017 · International Journal of Biological Markers
91. Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients
    Congxiang Shao, Junzhao Ye, Fuxi Li, Yansong Lin, Tingfeng Wu, Wei Wang, Shi‐Ting Feng, Bihui Zhong · 2019 · Digestive Diseases and Sciences
92. Vitamin D Is Associated with Severity and Mortality of Non-alcoholic Fatty Liver Disease: A US Population-based Study
    Hyun‐Seok Kim, Laura Rotundo, Neil Kothari, Sung‐Hoon Kim, Nikolaos Pyrsopoulos · 2017 · Journal of Clinical and Translational Hepatology
93. Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes
    SABINE KAHL, Anne Pernille Ofstad, Bernard Zinman, Christoph Wanner, Elke Schueler, Naveed A. Sattar, Silvio E. Inzucchi, Michael Roden · 2022 · Diabetes Obesity and Metabolism
94. Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort
    Sharma, Divya, Gotlieb, Neta, Farkouh, Michael E., Patel, Keyur, Xu, Wei, Bhat, Mamatha · 2022 · Journal of the American Heart Association
95. Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea
    Donghee Kim, Aijaz Ahmed, Clete A. Kushida · 2018 · Journal of Clinical Sleep Medicine
96. Key genes associated with non-alcoholic fatty liver disease and acute myocardial infarction
    Weiran Dai, Yue Sun, Zhiyuan Jiang, Kuan Du, Ning Xia, Guoqiang Zhong · 2020 · Medical Science Monitor
97. Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
    Giulio Marchesini, Elisabetta Bugianesi, Patrizia Burra, Fabio Marra, Luca Miele, Anna Alisi, Piero Vajro, Mario Masarone, Salvatore Petta, Marcello Persico et al. · 2021 · Nutrition Metabolism and Cardiovascular Diseases
98. The prevalence and predictors of metabolic dysfunction‐associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults
    Brandon J. Perumpail, Richie Manikat, Karn Wijarnpreecha, George T. Cholankeril, Aijaz Ahmed, Donghee Kim · 2024 · Journal of Pediatric Gastroenterology and Nutrition
99. Mortality Caused by Chronic Liver Disease Among American Indians and Alaska Natives in the United States, 1999–2009
    Anil G. Suryaprasad, Kathy K. Byrd, John Terrell Redd, David G. Perdue, M. Michele Manos, Brian J. McMahon · 2014 · American Journal of Public Health
100. Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States
     Donghee Kim, Won Kyum Kim, Min‐Sun Kwak, Goh Eun Chung, Jeong Yoon Yim, Aijaz Ahmed · 2017 · PLoS ONE